Combining rational design and directed evolutionof the human fibronectin-derived monobody scaffold, “PDbody”was engineered to bind to PD-L1 with a preference for a slightly lowerpH, which is typical in the tumor microenvironment. The gene discussed is FN1; the disease is neoplasm.